The Recognition Gap: Why Dementia Care Fails Before Treatment Begins

What if a person with dementia is not being overlooked once, but twice: first when their behavior is misread, and again when their treatment options are never fully offered?

A person who sleeps through much of the day may appear peaceful, exhausted, or simply to be declining. A Black person with dementia may leave a medical system with fewer prescriptions than a white person, even after accounting for age, sex, and insurance. These facts can seem unrelated. One concerns the strange architecture of sleep; the other concerns racial inequality in medicine.

But they reveal the same deeper problem: dementia care depends on whether the system recognizes a person’s needs before those needs become unmistakable.

This is the recognition gap. It appears when a symptom is normalized instead of investigated, when a family’s concern is treated as anecdotal, or when a patient is not connected to the specialist most likely to widen the menu of care. The result is not always an obvious refusal. More often, it is a quiet narrowing of possibilities.

The first failure is not ignorance. It is premature interpretation

Sleep changes are common in dementia, particularly in later stages. A person may sleep during the day, wake repeatedly at night, become confused in darkness, or mistake the early morning for the beginning of a workday. In Lewy body disease, daytime sleepiness may coexist with restless nights, nightmares, hallucinations, sleep apnoea, or restless legs.

The danger is not in knowing that these patterns can occur. The danger is in allowing that knowledge to end the investigation.

There is a crucial difference between saying, “This can be typical in dementia,” and saying, “Nothing else needs attention.” The first statement provides context. The second closes a door. Excessive sleep may reflect the progression of dementia, but it may also be intensified by medication effects, depression, pain, infection, dehydration, poor nighttime lighting, breathing problems, or a disrupted body clock. A symptom can be common and still deserve careful assessment.

Consider two families. In the first, an older woman sleeps from late morning until midafternoon and is awake, frightened, and hallucinating at night. Her family is told that this is simply what dementia does. They adapt the household around the problem, perhaps reducing visits and assuming that engagement is no longer possible. In the second, a clinician asks about recent medication changes, breathing during sleep, falls, pain, the lighting near the toilet, and the difference between her alertness at breakfast and at dinner. The visible behavior is the same. The care pathway is not.

The difference lies in whether the symptom is treated as a label or as a clue.

A label says: daytime sleeping, expected. A clue asks: what is the body, environment, or treatment trying to tell us? This distinction matters because dementia does not erase the rest of medicine. People with dementia can still develop sleep apnoea, urinary infections, medication side effects, restless legs, grief, anxiety, and pain. Cognitive impairment makes it harder for them to describe these problems, which increases the responsibility of observers and clinicians to notice patterns.

A common symptom is not a meaningless symptom. It is often a common signal that requires more skilled interpretation.

The second failure is unequal access to possibility

The same recognition gap operates at the level of treatment. In a large study of people with dementia, Black patients received five commonly prescribed medication classes less often than white patients. The differences persisted after researchers accounted for factors including age, sex, and insurance type. The study could not determine precisely how much of the gap came from prescribing decisions, affordability, patient preferences, or other factors, but the disparity itself is difficult to dismiss.

One especially revealing finding was that Black patients who saw a neurologist received certain dementia medications at rates more comparable to white patients. This suggests that access to specialist evaluation may act as a gate through which treatment possibilities become more evenly distributed.

The important insight is not that every person should receive a particular medication. Dementia drugs have benefits, limitations, side effects, and different levels of usefulness depending on diagnosis and stage. The deeper issue is whether people are receiving an equally serious evaluation of what might help.

A prescription is only the visible endpoint of a chain. Before it comes recognition of the condition, referral, diagnostic confidence, discussion of risks and benefits, medication access, follow up, and adjustment over time. Inequality can enter at any link. If a patient is less likely to be referred to a neurologist, then the problem may occur before anyone has the opportunity to make a prescribing decision.

This is why disparities are often hard to see. There may be no single dramatic act of exclusion. Instead, one person receives a specialist referral, a medication review, and a follow up appointment. Another receives reassurance, a brief office visit, and an assumption that little can be done. Both encounters may look polite. Only one preserves the full range of options.

The same pattern can occur in a household responding to sleep changes. One family is taught how to distinguish ordinary progression from warning signs, how to review medications, and how to improve nighttime safety. Another is told to expect disruption and endure it. Again, no one needs to announce that the second person matters less. The narrowing happens through omission.

Care is a system of interpretation, not a list of interventions

It is tempting to think of dementia care as a collection of tasks: diagnose the disease, prescribe medication, manage sleep, prevent falls, support the family. Yet these tasks depend on a prior activity that receives less attention: interpretation.

What does this behavior mean? What has changed? Which explanation is most plausible? Who should be involved? What options have not yet been considered?

A useful way to understand this is to imagine a hospital corridor with several doors. One door leads to a routine explanation. Another leads to a medication review. Another leads to sleep assessment. Another leads to neurology. Another leads to social support or financial assistance. A system with a strong recognition culture does not force every patient through every door. It makes sure the relevant doors are visible and that the patient is not excluded from them by habit, stereotype, or administrative friction.

This framework also explains why family observations matter. A person with dementia may not be able to report that they wake gasping, feel frightened in the dark, or mistake sunrise for the start of the workday. Family members often see the sequence that a short appointment cannot: sleeping at noon, wandering at 2 a.m., becoming more confused after a new prescription, or appearing alert only in a particular setting.

Family observations are not a substitute for clinical judgment. They are data. Treating them as emotional noise creates a form of diagnostic blindness, especially when the family is already struggling to be heard.

The same principle applies to racial disparities. Demographic patterns are not proof that every clinician has acted wrongly in every case. They are signals that the system may be producing unequal opportunities for evaluation and treatment. A responsible response is not to assign a motive automatically, but to ask where the pathway diverges and how to make it more consistent.

This yields a practical model with three questions:

1. What changed? Establish the timeline rather than treating the current behavior as a permanent trait.
2. What else could explain or worsen it? Look for medical, psychological, environmental, and treatment related contributors.
3. Who has not yet been included? Consider specialists, caregivers, pharmacists, social workers, and the patient’s own account of preferences and burdens.

These questions protect against two opposite errors. The first is overmedicalizing every behavior. The second is accepting every behavior as inevitable. Good care lives between those errors.

The most powerful intervention may be widening the next question

When a person with dementia sleeps much of the day, the immediate goal is not necessarily to make them stay awake. The goal is to understand whether the pattern is comfortable, safe, and consistent with their wishes and stage of illness. A careful review might examine nighttime routines, light exposure, mobility, pain, medication timing, breathing, hallucinations, and opportunities for meaningful activity during alert periods.

When a person has not received dementia related medication, the goal is not necessarily to prescribe it. The goal is to ensure that the decision was informed, individualized, and not silently determined by unequal access to a specialist or by assumptions about adherence, cost, family support, or likely benefit.

This is the difference between an intervention centered system and a possibility centered system. The first asks, “What can we do quickly?” The second asks, “What would we miss if we stopped here?”

For caregivers, the distinction can be translated into a simple record. Write down when the person sleeps, wakes, eats, becomes confused, experiences distress, or shows unusual movement or breathing. Note medication names and timing. Record changes over several days rather than relying on a single impression. This turns a vague concern into a pattern that can be discussed with a clinician.

For clinicians, the equivalent practice is to make the decision pathway visible. Explain why a medication is or is not appropriate. Ask what the patient and family understand. Review affordability and transportation rather than treating them as afterthoughts. Use referral criteria that are clear enough to reduce the influence of assumptions.

For health systems, equity requires more than publishing disparities. It requires measuring the steps that produce them: referral rates, time to specialist assessment, medication discussions, follow up, treatment discontinuation, and reasons for nonuse. If the only metric is whether a prescription appears in a record, the system may miss the earlier point at which a patient stopped being offered a full evaluation.

Key Takeaways

• Treat common symptoms as clues, not conclusions. Daytime sleepiness may occur in dementia, but review medication effects, breathing, pain, mood, infection, environment, and nighttime disruption.
• Track patterns before appointments. A brief log of sleep, alertness, confusion, hallucinations, falls, and medication timing can reveal changes that are difficult to describe from memory.
• Ask what options were considered, not only what was prescribed. A decision can be appropriate only when the relevant alternatives, benefits, risks, and burdens were actually discussed.
• Request specialist input when the situation is complex or changing. Neurology and other specialist referrals may help clarify diagnosis and reduce unequal access to treatment discussions.
• Make barriers explicit. Cost, transportation, caregiving capacity, language, and trust should be discussed directly rather than inferred from a patient’s identity or circumstances.

The central lesson is not that every sleep disturbance requires a medical workup or that every person with dementia should receive medication. It is that dementia care becomes unjust when uncertainty is distributed unevenly. Some people receive investigation, explanation, and choice. Others receive normalization and resignation.

That difference can begin with something as ordinary as a person sleeping at noon, or as administrative as a missing referral. In both cases, the decisive question is whether anyone pauses long enough to ask what the signal means and what door should open next.

Dementia may progressively alter memory, language, and orientation. It should not reduce the standard of curiosity applied to a person’s life. The fairest system is not the one that promises the same treatment to everyone. It is the one that makes sure everyone receives the same seriousness before treatment decisions are made.